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Pandemic virus emergenceAcquisition of α2-6 sialoside receptor speciﬁcity by α2-3 speciﬁc highly-pathogenic avian inﬂuenza viruses
(H5N1) is thought to be a prerequisite for efﬁcient transmission in humans. By in vitro selection for binding
α2-6 sialosides, we identiﬁed four variant viruses with amino acid substitutions in the hemagglutinin
(S227N, D187G, E190G, and Q196R) that revealed modestly increased α2-6 and minimally decreased α2-3
binding by glycan array analysis. However, a mutant virus combining Q196R with mutations from previous
pandemic viruses (Q226L and G228S) revealed predominantly α2-6 binding. Unlike the wild type H5N1,
this mutant virus was transmitted by direct contact in the ferret model although not by airborne respiratory
droplets. However, a reassortant virus with the mutant hemagglutinin, a human N2 neuraminidase and inter-
nal genes from an H5N1 virus was partially transmitted via respiratory droplets. The complex changes
required for airborne transmissibility in ferrets suggest that extensive evolution is needed for H5N1 transmis-
sibility in humans.
Published by Elsevier Inc.Introduction
Circulation of H5N1 highly pathogenic avian inﬂuenza virus in
Asia, Europe and Africa has resulted in more than 550 human
infections since 2003, with a case fatality ratio exceeding 58%
(WHO-CSR, 2011). This number of human cases is just a minute frac-
tion of the large number of people likely exposed to H5N1 during
thousands of H5N1 outbreaks reported in poultry (Kilpatrick, 2006;
OIE, 2007; Wang et al., 2008), indicating that virus transmission
from birds to humans is very inefﬁcient. Likewise, further virus trans-
mission from person-to-person is rare (Kandun et al., 2006; Wang et
al., 2008). However, the few cases of suspected human-to-human
spread are a threat to public health because of the possibility that
modest functional changes in the virus may confer transmissibilitytop G-16, Centers for Disease
30333, United States. Fax: +1
lar Medicine, University of Co-
nc.in the human population causing a new inﬂuenza pandemic (Olsen
et al., 2005; Yamada et al., 2006).
Efﬁcient infection and transmission of avian inﬂuenza viruses be-
tween birds depend in part on the high afﬁnity of the viral hemagglu-
tinin (HA) for α2-3 sialoglycan receptors which are typically found on
cells of the avian intestinal and respiratory tracts (Ito et al., 2000;
Vines et al., 1998). In contrast, human inﬂuenza A viruses bind with
high afﬁnity to α2-6-sialoglycans and poorly if at all to α2-3-
sialoglycans (Carroll and Paulson, 1985; Chen et al., 2011; Gambaryan
et al., 1995, 2005b; Rogers and D'Souza, 1989; Rogers and Paulson,
1983; Stevens et al., 2006a). The fact that α2-6 speciﬁcity was exhib-
ited by the earliest pandemic inﬂuenza viruses with HA genes of avian
origin in 1957 (H2) and 1968 (H3) has suggested that an emerging
H5N1 virus with preference for α2-6-sialoglycan receptors could
also become highly infectious and contagious for humans (Chutini-
mitkul et al., 2010; Knossow et al., 2002; Maines et al., 2006, 2011;
Matrosovich et al., 2000; Salomon et al., 2006). Several H5N1 clinical
isolates from humans have acquired incremental α2-6-sialoglycan
binding activity without concomitant loss of α2-3-sialoglycan
binding (Yamada et al., 2006). However, lack of transmission to
household members or healthcare personnel indicates that additional
functional changes are a prerequisite for high infectivity and trans-
missibility in humans.
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predictive understanding of the structural and functional changes in
the avian H5 HA that could impart high transmissibility in humans,
drawing from the H1, H2 or H3 HA subtypes from the three pan-
demics of the past century. Transmission studies in the ferret model
revealed lack of respiratory droplet H5N1 transmission, even when
reassorted with human inﬂuenza virus “internal genes”, suggesting
inadequate HA and NA functions (Maines et al., 2006). Studies with
the 1918 H1N1 pandemic virus showed that its transmissibility in a
ferret model correlated with preferential binding of α2-6-
sialoglycan by HA and simultaneous loss of α2-3-sialoglycan binding
(Tumpey et al., 2007b). In the present study, we exploited glycomic
and genetic approaches to identify variant H5N1 viruses with pre-
dominant binding to α2-6-sialoglycans. We used α2-6-sialoglycan-
coated magnetic beads to drive in vitro evolution of a contemporary
H5N1 virus in consecutive passages to identify spontaneous variants
that increased α2-6 speciﬁcity. We suggest that in vitro-selected mu-
tant viruses will help identify HA structural and functional changes
associated with human-like receptor recognition that will be valuable
for understanding the changes needed to affect receptor speciﬁcity
changes in inﬂuenza, and for monitoring the evolution of H5N1 ﬁeld
viruses toward a potentially pandemic form.
Results
In vitro selection of H5N1 receptor variants
The current model for emergence of pandemic inﬂuenza viruses
from avian sources postulates a switch in sialic acid receptor prefer-
ence from α2-3 sialoglycan to α2-6 sialoglycan structures (Knossow
et al., 2002; Rogers et al., 1985; Tumpey et al., 2007b). Mutations in
the HA gene of recent H5N1 isolates collected from humans indicate
that receptor speciﬁcity can evolve in this direction, either as a conse-
quence of selection in the human host, or possibly in response to the
abundance of α2-6 sialoglycan receptors in the intestine of terrestrial
poultry, such as chicken and quail (Gambaryan et al., 2005a; Guo et
al., 2007; Yamada et al., 2006). To examine the functional evolution
of H5 HA receptor speciﬁcity in the laboratory, we implemented an
in vitro receptor-binding virus enrichment approach that recapitu-
lates in vivo selection. Synthetic 6′-sialyl (N-acetyl-lactosamine) (6′
SLN) was used as the afﬁnity ligand mimicking the human receptor
to capture spontaneous viral receptor variants on the surface of mag-
netic beads. Starting with a pool of 108 EID50 of A/Vietnam/1203/2004
(VN04 virus), we performed four consecutive rounds of in vitro bind-
ing and elution followed by isolation of 150 individual virus clones by
plaque puriﬁcation and characterization by sequence analysis.
Eleven of 150 (7.3%) virus plaques sequenced had one non-
synonymous mutation in the HA1 region of the HA. These 11 variant
virus plaques corresponded to 8 unique substitutions in the HATable 1
In vitro selection of avian inﬂuenza variants with α2-6 sialoglycan beads.
Mutation in HAa H5 numbering Frequency
Wildtype VN04 – 139
A39T 29 1
K157Q 153 1
D187G 183 1
E190G 186 1
Q196R 192 2
S227N 223 1
E255K 251 3
H295Q 292 1
a Mutation is denoted as the amino acid in the wildtype virus (in single letter amino
acid notation) followed by the position in the mature HA and the amino acid found in
the variant virus. Positions are shown in the H3 numbering system, equivalent to A29,
K153, D183, E186, Q192, S223, E251, and H292 in the H5 protein.(Table 1). Substitutions at positions 187, 190, 196 and 227 (H3 num-
bering) were located in the receptor binding site (RBS) or its close
proximity, whereas position 157 is located at the tip of the molecule.
In contrast, positions 39, and 295 are located more distantly from this
site toward the stem, whereas position 255 is predicted to be buried
at the trimer interface. Some of the mutations near the receptor bind-
ing pocket had been previously documented in natural isolates of
H5N1 viruses (Yamada et al., 2006). Interestingly, the Q196R muta-
tion is found exclusively in three human isolates (A/Iraq/659/2006,
A/Iraq/756/2006, and A/Vietnam/3028II/2004-clone3; GenBank ac-
cessions EU146876 and EU146878.1) and one avian isolate (A/chick-
en/Reshoty/02/2006; accession CY047483). The S227N mutation has
also been reported primarily in human isolates (with the single ex-
ception of A/wild duck/Liaoning/8/2006; HM172084) and was noted
to mediate increased α2-6-sialoglycan receptor binding (Shinya et
al., 2005; Yamada et al., 2006). The higher frequency of H5N1 viruses
with these changes among human cases is consistent with the posi-
tive selection of variants with higher avidity for α2-6 sialosides
during replication in the human airway. The D187G and E190G muta-
tions were not present in any other H5N1 isolates. However, previ-
ously reported mutations E190D and N186K at or near these
positions markedly reduced α2-3 sialoside binding, consistent with
a functional role for the E190D mutation (Stevens et al., 2006b;
Yamada et al., 2006). Taken together, these results support the rele-
vance of the in vitro evolution approach to examine the development
of H5 mutations that increase avidity for the human-like α2-6 sialo-
glycan receptors.
Differential interaction of H5N1 virus variants with sialoglycans
To analyze the receptor-binding phenotype of viruses selected by
in vitro evolution we employed two binding assays with different
characteristics; a sialoglycan-ELISA and a sialoglycan microarray.
The sialoglycan ELISA measures multivalent binding of polymeric
molecules containing isomers of sialyl-lactosamine (3′SLN-PAA as a
model avian-type receptor and 6′SLN-PAA as human-type receptor)
to virions adsorbed onto a polystyrene multiwell plate (Gambaryan
and Matrosovich, 1992). The sialoglycan microarray detects the mul-
tivalent binding of virions to a diverse spectrum of naturally occur-
ring sialylated oligosaccharides covalently-linked to a glass surface
(Blixt et al., 2004; Stevens et al., 2006a).
In the ELISA based assay, the parental wild-type (wt) VN04 virus
showed an absolute preference for α2-3-sialoglycan (3′SLN) binding,
opposite to the α2-6 preference of a seasonal H3N2 human virus, A/
Memphis/12/1988 (Fig. 1). Five of the 8 variant VN04 viruses;
D187G, E190G, Q196R, S227N, and E255K, had increased binding to
6′ sialyl-lactosamine relative to WT parental virus (Fig. 1). However,
the binding to 6′SLN was observed at much higher sialoglycan con-
centrations compared to A/Memphis/12/1988 virus, indicating that
the interactions were weak relative to the 3′SLN binding. Variants
S227N, D187G, E190G, and Q196R had more signiﬁcant gains in 6′
SLN binding than variant E255K. Since the 6′SLN-PAA used in this
assay is the same sialoside conjugate used in the in vitro selection pro-
cedure, it is notable that this assay readily detects subtle increases in
avidity to α2-6 sialosides.
Except for the E255K mutant, the mutations showing increased
binding to α2-6 sialosides are located within two distinct structural
elements of the receptor binding site of HA; amino acid residues
187, 190, 196 are located in the 190-helix, whereas residue 227 oc-
cupies a central position in the 220-loop (Wiley and Skehel, 1987).
These elements are critical determinants of interactions with
galactose-2 and distal monosaccharides toward the reducing end of
sialoglycan receptors (Ha et al., 2001; Stevens et al., 2006b). There-
fore, structural changes of variant HAs are fully consistent with the
observed receptor function differences. Mutations at positions 39,
157, and 295 did not affect sialoside binding speciﬁcity as compared
Fig. 1. Solid phase receptor binding assay of H3N2 and H5N1 variant viruses compared to wildtype. Binding of sialylglycopolymers 3′SLN-PAA (blue line) and 6′SLN-PAA (red lines)
by inﬂuenza H3N2 and H5N1 viruses performed as described in Materials and methods section. The x axis denotes the concentration of biotinylated sialoglycan (μM) added to the
wells, the y axis indicates the resulting absorbance reading. Data shown are representative from three independent binding experiments.
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relative to the receptor binding site.
To achieve a better understating of the repertoire of glycans bound
by variant viruses, we used a glycan microarray that contains 50 sia-
loglycans covalently attached to the glass surface (Blixt et al., 2004;
Stevens et al., 2006a, 2006b). The in vitro selected variants with in-
creased 6′ SLN sialoglycan binding in the ELISA assay were analyzed
by glycan microarray. To rule out the contribution of mutations in
other virion surface proteins, these variants were re-derived by re-
verse genetics (rg) and phenotypically re-conﬁrmed by ELISA (data
not shown). The glycan array showed that the wt VN04-rg virus has
strong preference for α2-3-linked sialoglycans (Fig. 2), and weak
binding to α2-6-linked sialoglycans, with signiﬁcant binding to only
two α2-6 sialylated biantennary glycans (Fig. 2, glycan #39–40).
Compared to the wt VN04 virus, the three 190-helix variant viruses
showed minimal increased binding to α2-6 sialoglycans, resembling
the proﬁle of wt VN04 (Fig. 2), whereas the S227N variant showed a
substantial increase in binding to several additional α2-6-sialoglycans,
including a long α2-6-sialylated di-N-acetyllactosamine (Fig. 2, glycan
#47) and fucosylated α2-6 tri-N-acetyllactosamine (Fig. 2, glycan
#48). Both of these sequences contain the 6′SLN sequence used in the
in vitro selection experiments. However, increased binding afﬁnity to-
ward the shorter α2-6-linked sialyl-lactosamine (6′SLN) was not
detected using the glycan microarray (glycans #44–45).
The speciﬁcity analysis using both the ELISA and glycan micro-
array assays demonstrated that the in vitro selection protocol
yielded variants with weak but increased avidity for binding α2-
6 sialoglycans, with minimal changes in binding to α2-3-
sialoglycans. The ELISA assay appeared to be more sensitive than
microarray for picking up these changes, which we attribute to a
lower binding detection threshold (Figs. 1–2). In contrast, the glycan
microarray is valuable for simultaneously assessing the impact of the
change in speciﬁcitywith respect to the diverseα2-3 andα2-6 sialogly-
can structures found in nature. Thus, both assays are valuable.Receptor binding by viruses with dual 190-helix and 220-loop mutations
In the human pandemics of the previous century, at least two mu-
tations in the receptor binding pocket have been implicated in chang-
ing receptor speciﬁcity from preferential recognition of α2-3-
sialoglycans to recognition of α2-6 sialoglycans (Matrosovich et al.,
2000; Rogers et al., 1983; Tumpey et al., 2007a). For recent human
H5N1 isolates, two or more changes have been implicated in the in-
crease α2-6-linked sialoside recognition and binding to human air-
way tissues (Chutinimitkul et al., 2010; Yamada et al., 2006). Based
on the sporadic detection of HA S227N substitutions in human
H5N1 isolates, we reasoned that any of the 3 in vitro-selected muta-
tions in the 190 helix region of HA could be potentially co-selected
(e.g. S227N-D187G), yielding dual mutations that would synergize
to increase the speciﬁcity for α2-6 sialoglycans. To test this, double
mutants pairing S227N with one of the three 190-helix mutations
were generated by reverse genetics to analyze their receptor binding
properties by sialoglycan ELISA and arrays. The sialoglycan-ELISA
assay revealed a slightly additive effect of the pairwise mutations on
sialoglycan binding; 227N-187G, and 227N-196R showed a slightly
increased α2-6-linked sialyl-lactosamine (6′SLN) binding at lower
glycan concentrations as compared to viruses with a single amino
acid change (Fig. 3).
This increase in avidity was also evident in the glycan array
analysis of 227N-187G, and 227N-196R double mutant viruses,
which demonstrated binding to additional α2-6-sialoglycans, in-
cluding sulfated α2-6-linked sialyllactosamine (Fig. 2, glycan
#38) and α2-6 sialylated N, N′- diacetyllactosediamine (LacDiNac,
#47); both glycans have been detected in human or animal tissue
(Fig. 2) and are reported to be recognized by human inﬂuenza vi-
ruses (Crottet et al., 1996; Degroote et al., 2003; Stevens et al.,
2010). During propagation of the VN04 227N-190G mutant in
eggs or cell culture, additional mutations in HA1 were detected
as subpopulations, suggesting that additional mutations are
Fig. 2. Glycan microarray analysis of H5N1 variant viruses and including dual mutations from previous pandemic viruses. Different types of sialoglycans on the array (x-axis) are
indicated by colors; the structure of each numbered glycan is provided in Table S1. Vertical bars denote mean binding signal (ﬂuorescence intensity) and T bar extensions indicate
the standard error.Glycan microarray analysis of H5N1 variant viruses and including dual mutations from previous pandemic viruses. Different types of sialoglycans on the array (x-
axis) are indicated by colors; the structure of each numbered glycan is provided in Table S1. Vertical bars denote mean binding signal (ﬂuorescence intensity) and T bar extensions
indicate the standard error.
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ratory hosts. Therefore, the receptor binding properties of this
double mutant virus were not further characterizedFig. 3. Solid phase receptor binding assay of H5N1 variant with dual mutations close to the
PAA (red lines) by inﬂuenza H5N1 variants was described in Materials and methods section.
binding experiments.Taken together, these results suggested that a combination of mu-
tations arising independently within the 190-helix and 220-loop of
H5N1 HA molecule may synergize to enhance binding of α2-6receptor binding site. Binding of sialylglycopolymers 3′SLN-PAA (blue line) and 6′SLN-
The x and y axis are as in Fig. 1. Data shown are representative from three independent
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tions selected in this in vitro study revealed increased binding to a
limited number α2-6 sialoglycans while retaining a strong preference
for α2-3 sialoglycans.
Introduction of α2-6 speciﬁcity determinants of H2 and H3 pandemic
viruses into H5N1 receptor variants
Previous studies showed that the mutations conferring α2-6 spec-
iﬁcity in H2 and H3 human pandemic viruses (i.e. Q226L/G228S) pro-
duced only an incremental switch in α2-6 speciﬁcity when
introduced into the H5 HA framework (Stevens et al., 2006a, 2008).
The corresponding mutant H5N1 viruses retained a relatively high
avidity for α2-3-receptors (Stevens et al., 2008), which is not found
in human H1, H2 and H3 isolates. Additional amino acid changes pre-
sent in circulating strains of H5N1 close to RBS or different mutations
in the 220 loop were found to further polarize the receptor binding of
226L/228S mutant H5N1 viruses toward α2-6 glycans. In particular,Fig. 4. Glycanmicroarray analysis of clade 2 H5N1 viruseswith dualmutations close to the receincorporating an Arginine at position 193 and lack of glycosylation at
Asparagine 158 found in thewidely circulating clade 2.2 viruses showed
the most prominent “receptor switch” (Stevens et al., 2008). Since the
196R variant identiﬁed by in vitro selection has also been identiﬁed
among recent human isolates from clade 2.2 viruses, we evaluated the
three in vitro selected 190-loop mutations 187G, 190G, and 196R for
their effect on receptor speciﬁcity of viruseswith anH5 clade 2.2 frame-
work containing the 220-loop receptor switch mutations; A/egret/
Egypt/1162/2006-226L/228S (EG06-226L/228S).
Glycan array analysis showed that introducing any one of the
three 190 loop mutations into the EG06-226L226S framework signif-
icantly increased the switch to α2-6 speciﬁcity (Fig. 4). In particular,
the EG06-187G/226L/228S or EG06-190G/226L/228S viruses showed
a notable decreased afﬁnity for α2-3 sialoglycans. Remarkably, the
EG06-196R/226L/228S virus exhibited little α2-3 sialoglycan binding
and strong binding to α2-6 sialoglycans (Fig. 4). Thus, unlike the
natural human H5N1 isolates that exhibit weak binding to α2-6
sialosides and strong binding to α2-3 sialosides, this mutant exhibitsptor binding site. The color conventions and glycan key for the charts are described in Fig. 2.
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human inﬂuenza viruses of 1957 and 1968.
In vivo studies in the ferret model
To establish the in vivo consequences of receptor speciﬁcity
changes identiﬁed in vitro, these mutant H5N1 viruses were analyzed
in a ferret model. Virus was administered to ferrets by intranasal in-
oculation and the following day infected animals were co-housed
with naive ferrets to test for transmission by direct contact and adja-
cent to cages with additional uninfected ferrets to test for transmis-
sion via airborne respiratory droplets. After intranasal inoculation
into ferrets, the wild type rg EG06 virus reached a peak titer
~104 pfu/ml in nasal washes at 3 days post infection (data not
shown). No infection of contact ferrets was detected by virus shed-
ding or seroconversion (Table 2), as reported in earlier studies with
H5N1 viruses (Maines et al., 2006). In contrast, when the ferrets
were infected with EG06-196R/226L/228S virus, viral shedding was
detected in the nasal secretions of direct contact ferrets, although
no infection was evident in ferrets exposed to respiratory droplets
(Table 2). The results suggest that a measurable increase in H5N1
virus transmission via direct contact in ferrets can be imparted by
modiﬁcation of HA molecules approximating a human virus receptor
speciﬁcity.
Efﬁcient human-to-human transmission of inﬂuenza virus re-
quires not only proper receptor binding, but also a balanced neur-
aminidase activity and other viral replication characteristics
determined by the replicative machinery encoded by the internal
genes. To investigate their role in transmission, the EG06 H5 HA mu-
tant was placed into a VN04 virus background by reverse genetics.
The N1 neuraminidase of H5N1 is predicted to maintain α2-3 sialo-
side speciﬁcity as a result of its long co-evolution with H5 HA mole-
cules that bind α2-3 sialoglycans in avian species (Raab and
Tvaroska, 2010). A reverse genetics virus with HA of EG06-196R/
226L/228S, the N2 neuraminidase from a human seasonal H3N2
virus, A/Brisbane/10/2007, and 6 internal genes from a clade 1
H5N1 virus, VN04, known to replicate efﬁciently in ferrets (Maines
et al., 2011), was generated and evaluated in the ferret transmission
model. As shown in Table 2, both direct contact ferrets that were
housed in the same cage with inoculated ferrets became infected, as
evidenced by virus shedding and seroconversion results. In addition,
viral shedding was also detected in one of two ferrets housed in adja-
cent cages and exposed only via respiratory droplets. An analogous
reverse genetics virus with the N1 NA from a human seasonal H1N1
virus, A/Brisbane/59/2007 resulted in efﬁcient direct contact but not
respiratory droplet transmission (Table 2).
The results of these investigations indicate that combinations of
mutations surrounding the receptor binding pocket of the H5 HA
are able to switch receptor speciﬁcity to one that is stronglyα2-6 spe-
ciﬁc, characteristic of human inﬂuenza viruses, and that this receptor
speciﬁcity change is sufﬁcient to increase transmissibility betweenTable 2
Presence of virus in nasal secretions and seroconversion of inoculated ferrets and their con
Virus Inoculated ferrets Direct
Virus detection Sero-conversiona Virus
EG06 WT 2/2b 2/2 0/2
EG06-196R/226L/228S 2/2 2/2 2/2
cEG06-196R/226L/228S
-H3N2 NA
2/2 2/2 2/2
cEG06-196R/226L/228S
-H1N1 NA
2/2 2/2 2/2
a Hemagglutination-inhibition antibody titer of the convalescent serum sample is ≥4-fol
b Number of ferrets testing positive/total ferrets tested.
c Denotes internal genes from A/Vietnam/1203/2004 (H5N1).ferrets. However, lack of efﬁcient transmission by a virus that con-
tained a human virus neuraminidase demonstrates that a switch to
α2-6 speciﬁcity may be required, but is not sufﬁcient for emergence
of a pandemic virus from H5N1. Rather, efﬁcient transmission of
H5N1 or a reassortant virus containing H5N1 genes will require opti-
mization of both the HA, NA and internal genes.
Discussion
Highly pathogenic avian inﬂuenza viruses (H5N1) have become en-
zootic in avian populations in many countries, e.g. Vietnam, Indonesia,
and Egypt, where they continue to evolve rapidly (Melidou, 2009;
Sims, 2007). Despite very high case-fatality proportions in some coun-
tries, human cases remain sporadic and isolated, suggesting that efﬁ-
cient human infection and transmissibility depend on additional
functional changes in the virus. Poor binding to α2-6-linked receptors
is believed to be a major barrier preventing efﬁcient human infection
and transmissibility. However, extensive circulation of H5N1 viruses
in terrestrial poultry and sporadic infections in mammals have raised
the concern of evolution toward α2-6-linked human-like receptor
speciﬁcity as observed in the H9N2 viruses circulating in poultry and
pigs (Song et al., 2009; Takano et al., 2009; Wan and Perez, 2007;
Wan et al., 2008). A powerful approach to study this process was
reported by Rogers et al. (1985), who used in vitromethodologies to se-
lect a virus with human receptor speciﬁcity from an avian precursor,
mimicking in vivo adaptation to humans. In this study, we applied a
similar protocol to understand the potential of H5N1 viruses to increase
the chances of infecting and transmitting in humans. We opted for a 6′
SLN glycan as receptor analog for afﬁnity selection because wt H5N1 vi-
ruses exhibited excellent binding to 3′SLN but not 6′SLN with the criti-
cal α2-6 linkage (Stevens et al., 2006a).
This in vitro evolution study led to the identiﬁcation of four amino
acid substitutions located in the 190-helix and 220-loop of the HA re-
ceptor binding site, two of which (196R and 227N) have been found
almost exclusively in H5N1 viruses isolated from human cases, e.g.
in A/Vietnam/3028II/2004 clone 3 (Yamada et al., 2006). A recent
study (Watanabe et al., 2011) showed that a substitution from Q to
H at position 192 (i.e. Q196H in the corresponding H3 numbering
used in this study) in the HA of clade 2.2.1 H5N1 viruses circulating
in Egypt also revealed increased binding to α2,6 sialoglycans. These
substitutions mediated minimal changes in α2-3-sialoglycan binding
and limited increases in α2-6-sialoglycan binding. Notably, most re-
ceptor binding changes were detected by the ELISA assay and not in
glycan microarrays, demonstrating that the ELISA based assay may
be more sensitive at detecting slight changes in avidity to α2-6-
sialoglycans. These studies conﬁrmed previous observations regarding
the detection of receptor variants by the sialoglycan-ELISA method
(Yamada et al., 2006). However, as shown previously, these subtle
receptor binding changes were not sufﬁcient for efﬁcient infection and
transmission of H5N1 viruses bearing 196R and 227N mutations in
ferrets, an animal model believed to exhibit similar requirements totacts.
contact ferrets Aerosol contact ferrets
detection Sero-conversion Virus detection Sero-conversion
0/2 0/2 0/2
2/2 0/2 0/2
2/2 1/2 1/2
2/2 0/2 0/2
d greater than pre-inoculation sample.
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genetics generated viruses bearing pairwise combinations of indepen-
dently selected 187G and 196R with 227N mutations revealed incre-
mental increases in binding to α2-6 sialoglycans, but the viruses
retained a strong preference to α2-3 sialoglycans. These modest
changes of receptor speciﬁcity are in stark contrast with the very dra-
matic switch observed for the avian viruses responsible for the pan-
demics of 1957 and 1968 (Matrosovich et al., 2000; Pappas et al.,
2010; Rogers and Paulson, 1983), demonstrating that single or even
double mutations in the H5 framework are not sufﬁcient to effect the
switch to the ‘human type’ receptor speciﬁcity.
Having identiﬁed several mutations by in vitro evolution that
might contribute to a switch in receptor speciﬁcity, we assessed
their potential impact on the speciﬁcity of currently circulating
clade 2 H5N1 viruses. The clade 2.2 H5N1 viruses have become
enzooting in poultry in many Asian countries and Egypt, accounting
for a majority of documented human infections in recent years
(WHO-CSR, 2011). An additional motivation for choosing a clade 2.2
virus to evaluate the Q226L/G228S mutations was based on the iden-
tiﬁcation of the Q196R in the HA of human isolates of this clade. In a
previous investigation, multiple clades of H5N1 viruses bearing the
critical H2 and H3 mutations imparting human-like receptor binding
(Q226L/G228S) demonstrated a decreased but still signiﬁcant afﬁnity
for α2-3 sialoglycans (Stevens et al., 2008). Interestingly, when these
220-loop mutations were combined with a 190-helix mutation
(Q196R) yielding the EG06-196R/226L/228S triple mutant virus (clade
2.2)we observed amajor loss ofα2-3 sialoglycan binding, while retain-
ing strong binding to α2-6 sialoglycans, a pattern similar to that ob-
served in the 1957 and 1968 pandemic viruses (Matrosovich et al.,
2000; Pappas et al., 2010; Rogers and Paulson, 1983).
Previous studies indicated that H5N1 viruses with altered receptor
speciﬁcity may have reduce ﬁtness and compromised replication and/
or transmission efﬁciency in vivo (Maines et al., 2011). The replication
characteristics of the EG06-196R/226L/228S triplemutant virus in a fer-
retmodel resulted in increased transmission efﬁciency to direct contact
animals housed in the same cage. However, a low level of droplet trans-
mission to ferrets in adjacent cages was only detected when the EG06-
196R/226L/228S HA was inserted into the backbone of the highly viru-
lent A/Vietnam/1203/04 virus carrying the NA of a human H3N2 virus
(A/Brisbane/10/2007). These data reinforce the complex functional re-
quirements for in vivo generation of respiratory droplets that can infect
other animals. Although still poorly understood, such requirements
may include functional compatibility between HA and NA resulting in
efﬁcient virus attachment to cells of the upper respiratory tract and sub-
sequent release of progeny virions (Wagner et al., 2002).
Related studies reported by Maines et al. analyzed reassortant vi-
ruses that contained the internal genes of an H5N1 virus that was
not transmissible in ferrets and the HA and NA genes from a human
H3N2 virus that was transmissible (Maines et al., 2006). Despite the
efﬁcient replication of the reassortant viruses in the upper airway of
ferrets, these viruses exhibited poor transmission by direct contact,
and failed to transmit via respiratory droplets despite having a
human virus HA and NA (Maines et al., 2006). The lack of increased
transmission with the addition of the human HA and NA could be
due to many factors. However, it is worth noting that we selected
the internal genes of the VN04 H5N1 virus for our reassortant viruses
because of its efﬁcient replication in inoculated ferrets, yet it exhib-
ited inefﬁcient transmission by direct contact and no transmission
by respiratory droplets to contact ferrets. In contrast, there was re-
duced virulence in inoculated ferrets with the EG06 strain (Maines
et al., 2011). Thus, the selection of internal genes that support efﬁ-
cient replication of the virus may be important for revealing pheno-
typic changes affecting early events in the replication cycle, such as
those mediated by the HA and NA.
In conclusion, this in vitro evolution study led to identiﬁcation of
viruses with amino acid changes that impart increased α2-6 sialosidereceptor binding. One of these mutations introduced in a clade 2.2
H5N1 virus contributed toward increased respiratory droplet trans-
mission between ferrets only if combined with mutations observed
in previous pandemic viruses, as well as a human N2 NA and the in-
ternal genes from a clade 1 H5N1 virus. The complex genetic changes
required by a clade 2.2 H5N1 virus to reach a low level of transmissi-
bility in ferrets would indicate that considerable functional evolution
is still required for acquisition of transmissibility in humans.
Materials and methods
Viruses and cells
Highly pathogenic H5N1 viruses, A/Vietnam/1203/2004 (clade 1)
and A/egret/Egypt/1162/2006 (clade 2.2) herein VN04 and EG06 re-
spectively, were obtained from the WHO Global Inﬂuenza Surveillance
Network (WHO/FAO/OIE, 2007). The viruses were propagated in the al-
lantoic sac of 10–11 day embryonated chicken eggs for 24 h at 37 °C and
aliquoted stocks were stored at −80 °C. Viral infectivity was deter-
mined by plaque assay onMDCK cells or by endpoint dilution in chicken
eggs as described (WHO, 2002). Madin–Darby canine kidney (MDCK)
cells (cat # CCL-34) and Human Embryonic Kidney 293 (HEK293)
cells (cat # CRL-1573) were obtained from the American Type Culture
Collection and propagated in DMEM with 10% fetal bovine serum. All
experiments using H5 subtype highly pathogenic avian inﬂuenza virus-
es were conducted under biosafety level 3 containment (http://www.
cdc.gov/OD/ohs/biosfty/bmbl5/bmbl5toc.htm) including enhance-
ments required by the U.S. Department of Agriculture and Select
Agent Program (Richmond and Nesby-O'Dell, 2002), available at:
http://www.access.gpo.gov/nara/cfr/waisidx_06/9cfr121_06.html.
Receptor speciﬁcity variant virus selection
Neu5Acα2-6Galβ1-4GlcNAcβ-SpNH-polyacrylamide-30kD (6′SLN-
PAA) was prepared as previously described (Collins et al., 2006). The
6′SLN-PAA-coated matrix was prepared by incubating streptavidin
magnetic beads (Dynabeads M280) with 6′SLN-PAA-Biotin and subse-
quently removing the unbound glycans by buffer exchange, as de-
scribed previously (Collins et al., 2006). A VN04 virus pool containing
108 EID50 was incubated with 107 α2-6-sialoglycan magnetic beads in
a 0.45 ml volume for 10 min at 25 °C in DMEM/0.4% BSA and rinsed ex-
tensively to remove unbound virus. Virus attached to beads was eluted
by incubation with Clostridium perfringens sialidase (1 U/ml) for 3 h at
37 °C followed by magnetic separation. Released virus was ampliﬁed
by propagation in MDCK cells as described, except that the adsorption
step was done at 4 °C for 15–20 min followed by culture medium ex-
change. The binding, elution, ampliﬁcation cycle was repeated 4 times
to allow for sufﬁcient expansion of variants. Isolation of clonal virus
populations entailed identiﬁcation of well-isolated plaques formed on
MDCK monolayers under agarose as described previously (Tobita et
al., 1975). A total of 150 well-separated plaques were individually
selected from the material eluted after the fourth cycle of binding and
elution. Viral stocks from each clone were propagated in MDCK cells.
RT-PCR, nucleotide sequencing
Total RNA was extracted from tissue culture supernatant or allan-
toic ﬂuid using the QiAmp Viral RNA minikit (Qiagen) and reverse
transcribed to cDNA using a proprietary one-step reaction system
(RT-PCR kit Qiagen) and primers. PCR ampliﬁcation of the coding re-
gion of the inﬂuenza HA gene was performed as previously described
using universal gene-speciﬁc primer sets (primer sequences available
on request). The resulting DNA amplicons served as templates for au-
tomated sequencing on an Applied Biosystems 3100 automated DNA
sequencer using cycle sequencing dye terminator chemistry (ABI).
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chromatographs for both strands of the amplicon cDNA.
Virus receptor speciﬁcity analysis by sialoglycan ELISA
The procedure was adapted from Gambaryan et al. (Gambaryan
and Matrosovich, 1992). Brieﬂy, polystyrene microplates were coated
with fetuin (10 μg/ml) for 16 h. After four rinses with washing buffer
(0.01% Tween 80 in 0.2x PBS), plates were incubated with inﬂuenza
virus (32 HA units/50 μl in PBS). After incubation at 4 °C overnight,
the plates were rinsed four times with washing buffer. Wells were
ﬁlled with biotinylated 3′-SLN-PAA or 6′-SLN-PAA (Consortium for
Functional Glycomics, http://www.functionalglycomics.org) in wash-
ing buffer, supplemented with 1 μM zamanivir (GSK, Middlesex UK)
and 0.02% bovine serum albumin and incubated for 2.5 h on ice.
Assay plates were again rinsed four times with washing buffer, and
incubated with streptavidin-horseradish peroxidase (HRP)-conjugate
at 4 °C for 1 h. Assay plates were rinsed ﬁve times with washing buff-
er and incubated with TMB/hydrogen peroxide substrate (BD Phar-
mingen) for 20 min at room temperature; absorbance was
determined at 450 nm after stopping the reaction with 0.1 N HCl. As-
says were repeated three times.
Glycan speciﬁcity of virions by microarray analysis
Analysis of the receptor speciﬁcity of inﬂuenza virus using glycan
microarrays was done essentially as described previously (Blixt et al.,
2004; Stevens et al., 2006a). Custom microarrays for inﬂuenza re-
search were produced for the CDC on NHS activated glass slides
(Schott Nexterion, Mainz, Germany) using a glycan library provided
by the Consortium for Functional Glycomics (Table S1 for list of gly-
can structures). Virus preparations were diluted to 1 ml into phos-
phate buffered saline containing 3% (w/v) bovine serum albumin
(PBS-BSA) to HA titers of 128. Virus suspensions were applied to
slides and subsequently incubated in a closed container with gentle
agitation for 1 h. Unbound virus was washed off by dipping slides se-
quentially in PBS. The slides were then overlaid with corresponding
primary antibodies (sheep anti-VN04) diluted in PBS-BSA, followed
by incubation with biotinylated secondary antibody for 30 min. Slides
were washed brieﬂy with PBS as above followed by application of the
avidin-Alexa ﬂuro 635 conjugates. All steps were performed at 4 °C.
After drying the slides in a steam of nitrogen they were immediately
scanned (ProScanArray HT slide scanner, Perkin Elmer or Genepix
Molecular Device) followed by image analysis with ImaGene 6.1 soft-
ware (Biodiscovery, Inc., El Segundo, CA).
Derivation of viruses by reverse genetics
Reassortant viruses were generated from plasmids by a reverse
genetics approach (Fodor et al., 1999; Hoffmann and Webster, 2000;
Neumann and Kawaoka, 1999). To generate viruses with amino acid
changes in HA, mutations were introduced using an overlap exten-
sion PCR approach (Urban et al., 1997). All new plasmids were se-
quenced to verify the absence of unwanted mutations. Viruses
derived by plasmid transfection of HK293 cells were propagated in
MDCK or eggs. The HA1 of resulting virus stocks were sequenced to
detect the emergence of revertants during ampliﬁcation.
Infections in the ferret model
Male ferrets, 6–12 months of age (Triple F Farms, Sayre, PA) sero-
logically negative by hemagglutination inhibition (HI) assay for cur-
rently circulating human seasonal inﬂuenza viruses (Matsuoka et al.,
2009) were used to assess viral transmissibility in vivo. Two animals
were inoculated intranasally with 106 PFU of virus diluted in 0.5 ml
PBS and housed in individual cages with perforated side-walls asdescribed previously (Maines et al., 2006). The following day (1 day
post-inoculation), one additional “direct contact” ferret was housed
in the same cage with each inoculated ferret. Two “respiratory droplet
contact” ferrets were placed in adjacent cages (one per cage) with a
perforated side-wall leaving a 5 cm gap between cages. Nasal washes
were collected as previously described (Zitzow et al., 2002) from all
ferrets on alternating days for 11 days and the concentration of viable
virus in these samples was determined by endpoint titration in MDCK
cells. Pre- and post-exposure ferret sera collected 14 days after virus
inoculation were analyzed in HI assay to assess seroconversion. The
HI assay was performed with 0.5% turkey red blood cells as previously
described (WHO, 2002). Animal studies were conducted under a pro-
tocol approved by the CDC Animal Care and Use Committee.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.virol.2011.10.006.
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